Aqtual - Crunchbase Company Profile & Funding

Q: Where is Aqtual's headquarters?

Aqtual is located in Hayward, California, United States.

Q: Who invested in Aqtual?

Aqtual has 5 investors including Genoa Ventures And Yu Galaxy.

Q: When was the last funding round for Aqtual?

Aqtual closed its last funding round on obfuscated from a Series B round.

Overview

Aqtual

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Aqtual

CB Rank

3339

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease.

Founded

obfuscation

Private

Series B

Hayward, California, United States

11-50

aqtual.com

Biotechnology

Health Care

Machine Learning

Wellness

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Diana Abdueva: Founder & CEO

Details

Legal Name

Aqtual, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Diana Abdueva

About the Company

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease. The company utilizes a novel cell-free DNA-based platform that evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood. The platform also yields

efficient and robust real-time analysis of disease and treatment while overcoming the limitations of previous cell-free DNA methodologies.

Phone Number

+1 341 208 8569

Contact Email

media@aqtual.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Aqtual is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Blood Test for Rheumatoid Arthritis Therapy Management

A blood test designed to identify biomarkers associated with treatment response in rheumatoid arthritis patients to guide therapy management.

Cell-Free DNA Analysis Platform

A platform that measures epigenetics, gene regulation, and transcriptomics from cell-free DNA in blood samples to identify disease-specific clinical features.

Research & Development

Aqtual is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Aqtual	5	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Genoa Ventures	—	Series B - Aqtual	—
Genoa Ventures	—	Series B - Aqtual	—
Genoa Ventures	—	Series B - Aqtual	—
Genoa Ventures	—	Series B - Aqtual	—
Genoa Ventures	—	Series B - Aqtual	—